Phase 3 Study of the Safety and Efficacy of OmegaD Softgels in the Treatment of Dry Eye Disease
Status:
Active, not recruiting
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
This is a phase 3 study to evaluate the safety and efficacy of OmegaD softgels for the
treatment of dry eye disease. A daily dose of 2 OmegaD softgels dosed orally BID will be
compared to 2 placebo softgels (mineral oil ) dosed orally BID for 84 days. Approximately 300
subjects will be evaluated for their signs and symptoms of dry eye disease and for safety
throughout the study.